We subsequently designed a more distinct probe, [18F]CFA, which was Utilized in The existing research To guage dCK activity in tumors when dealt with with a little molecule dCK inhibitor. This probe is also remaining examined in a very scientific demo at our establishment to evaluate variations in dCK action next most cancers immunotherapy 18. PET